期刊
CHEMMEDCHEM
卷 -, 期 -, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202300140
关键词
schistosomiasis; praziquantel; transient receptor potential melastatin; metabolite; structure-activity relationships
Praziquantel (PZQ) is an important anthelmintic drug that activates the TRPMPZQ ion channel in trematode worms. Recent findings suggest that the cyclohexyl ring of PZQ is crucial for its activity, as well as its metabolism. In this study, the in vitro and in vivo activities of PZQ analogues with improved metabolic stability were evaluated, along with the contribution of the parent drug and its main metabolite to overall activity in humans.
Praziquantel (PZQ) is an essential anthelmintic drug recently established to be an activator of a Transient Receptor Potential Melastatin (TRPMPZQ) ion channel in trematode worms. Bioinformatic, mutagenesis and drug metabolism work indicate that the cyclohexyl ring of PZQ is a key pharmacophore for activation of trematode TRPMPZQ, as well as serving as the primary site of oxidative metabolism which results in PZQ being a short-lived drug. Based on our recent findings, the hydrophobic cleft in schistosome TRPMPZQ defined by three hydrophobic residues surrounding the cyclohexyl ring has little tolerance for polarity. Here we evaluate the in vitro and in vivo activities of PZQ analogues with improved metabolic stability relative to the challenge of maintaining activity on the channel. Finally, an estimation of the respective contribution to the overall activity of both the parent and the main metabolite of PZQ in humans is reported.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据